388 related articles for article (PubMed ID: 7512718)
1. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.
Pusztaszeri MP; Seelentag W; Bosman FT
J Histochem Cytochem; 2006 Apr; 54(4):385-95. PubMed ID: 16234507
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
Ruck P; Xiao JC; Kaiserling E
Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
Manning T; Smoller BR; Horn TD; El Darouti M; Marzouk S; Hadidi HE; Ramadan S
J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
[TBL] [Abstract][Full Text] [Related]
5. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells.
Uccini S; Ruco LP; Monardo F; Stoppacciaro A; Dejana E; La Parola IL; Cerimele D; Baroni CD
J Pathol; 1994 May; 173(1):23-31. PubMed ID: 7523640
[TBL] [Abstract][Full Text] [Related]
8. The use of CD31 and collagen IV as vascular markers. A study of 56 vascular lesions.
Schmidt D; von Hochstetter AR
Pathol Res Pract; 1995 Jun; 191(5):410-4. PubMed ID: 7479359
[TBL] [Abstract][Full Text] [Related]
9. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
Fukunaga M
Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
[TBL] [Abstract][Full Text] [Related]
11. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma.
Pammer J; Plettenberg A; Weninger W; Diller B; Mildner M; Uthman A; Issing W; Stürzl M; Tschachler E
Am J Pathol; 1996 May; 148(5):1387-96. PubMed ID: 8623911
[TBL] [Abstract][Full Text] [Related]
12. Quantification of angiogenesis in cervical cancer: a comparison among three endothelial cell markers.
Vieira SC; Zeferino LC; Da Silva BB; Aparecida Pinto G; Vassallo J; Carasan GA; De Moraes NG
Gynecol Oncol; 2004 Apr; 93(1):121-4. PubMed ID: 15047224
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
14. Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1.
Huang YQ; Friedman-Kien AE; Li JJ; Nickoloff BJ
Arch Dermatol; 1993 Oct; 129(10):1291-6. PubMed ID: 7692824
[TBL] [Abstract][Full Text] [Related]
15. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue.
Shih IM; Nesbit M; Herlyn M; Kurman RJ
Mod Pathol; 1998 Nov; 11(11):1098-106. PubMed ID: 9831208
[TBL] [Abstract][Full Text] [Related]
16. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
Castro EC; Galambos C
Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
[TBL] [Abstract][Full Text] [Related]
17. Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues.
Remotti F; Fetsch JF; Miettinen M
Hum Pathol; 2001 Aug; 32(8):873-9. PubMed ID: 11521233
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.
Nielsen BS; Sehested M; Kjeldsen L; Borregaard N; Rygaard J; Danø K
Lab Invest; 1997 Oct; 77(4):345-55. PubMed ID: 9354769
[TBL] [Abstract][Full Text] [Related]
19. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.
Trojan L; Thomas D; Friedrich D; Grobholz R; Knoll T; Alken P; Michel MS
Anticancer Res; 2004; 24(3a):1651-6. PubMed ID: 15274336
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas.
Poncelet C; Fauvet R; Feldmann G; Walker F; Madelenat P; Darai E
J Surg Oncol; 2004 May; 86(2):84-90. PubMed ID: 15112250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]